Title | Type | SJR | H index | Total Docs. (2017) | Total Docs. (3years) | Total Refs. (2017) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2017) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Medicinal Chemistry | journal | 1.015 Q2 | 202 | 284 | 873 | 35541 | 2862 | 815 | 3.32 | 125.14 | |
2 | Current Immunology Reviews | journal | 0.124 Q4 | 23 | 16 | 50 | 1994 | 16 | 42 | 0.17 | 124.63 | |
3 | Current Pharmaceutical Design | journal | 0.883 Q2 | 183 | 620 | 1828 | 74679 | 5143 | 1667 | 2.66 | 120.45 | |
4 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.760 Q2 | 52 | 27 | 83 | 3115 | 216 | 78 | 2.43 | 115.37 | |
5 | Current Neuropharmacology | journal | 1.210 Q1 | 103 | 83 | 241 | 9247 | 912 | 213 | 3.28 | 111.41 | |
6 | Current Genomics | journal | 0.922 Q3 | 77 | 47 | 153 | 5193 | 358 | 132 | 2.10 | 110.49 | |
7 | Current Organic Chemistry | journal | 0.492 Q3 | 112 | 177 | 559 | 19009 | 1049 | 493 | 1.80 | 107.40 | |
8 | Current Topics in Medicinal Chemistry | journal | 0.885 Q2 | 133 | 262 | 747 | 27685 | 2168 | 649 | 3.09 | 105.67 | |
9 | Mini-Reviews in Medicinal Chemistry | journal | 0.567 Q2 | 107 | 115 | 399 | 12053 | 863 | 366 | 2.08 | 104.81 | |
10 | Current Drug Targets | journal | 0.906 Q2 | 119 | 140 | 536 | 14215 | 1303 | 481 | 2.13 | 101.54 | |
11 | Current Gene Therapy | journal | 0.951 Q1 | 80 | 44 | 140 | 4205 | 309 | 131 | 2.13 | 95.57 | |
12 | Current Protein and Peptide Science | journal | 0.858 Q2 | 96 | 124 | 246 | 11582 | 625 | 209 | 2.27 | 93.40 | |
13 | Current Cancer Drug Targets | journal | 0.951 Q1 | 103 | 69 | 223 | 6431 | 569 | 204 | 2.18 | 93.20 | |
14 | Current Stem Cell Research and Therapy | journal | 0.543 Q2 | 63 | 67 | 219 | 5888 | 383 | 193 | 1.64 | 87.88 | |
15 | Current Diabetes Reviews | journal | 0.879 Q2 | 68 | 51 | 146 | 4391 | 353 | 133 | 1.90 | 86.10 | |
16 | Mini-Reviews in Organic Chemistry | journal | 0.263 Q4 | 43 | 46 | 131 | 3737 | 110 | 116 | 0.63 | 81.24 | |
17 | Recent advances in inflammation & allergy drug discovery | journal | 37 | 13 | 61 | 1038 | 78 | 57 | 1.26 | 79.85 | ||
18 | Current Molecular Pharmacology | journal | 0.996 Q1 | 49 | 27 | 90 | 2153 | 168 | 75 | 1.90 | 79.74 | |
19 | Current Vascular Pharmacology | journal | 0.715 Q2 | 69 | 68 | 292 | 5333 | 555 | 233 | 1.71 | 78.43 | |
20 | CNS and Neurological Disorders - Drug Targets | journal | 0.863 Q2 | 96 | 125 | 504 | 9747 | 1140 | 436 | 1.83 | 77.98 | |
21 | Current Organic Synthesis | journal | 0.417 Q3 | 55 | 98 | 200 | 7339 | 346 | 188 | 1.48 | 74.89 | |
22 | Current Pharmacogenomics and Personalized Medicine | journal | 0.123 Q4 | 20 | 16 | 56 | 1195 | 7 | 52 | 0.05 | 74.69 | |
23 | Recent Patents on Biotechnology | journal | 0.317 Q3 | 42 | 18 | 77 | 1309 | 77 | 68 | 0.64 | 72.72 | |
24 | Current Cancer Therapy Reviews | journal | 0.140 Q4 | 17 | 11 | 81 | 742 | 13 | 68 | 0.06 | 67.45 | |
25 | Current Cardiology Reviews | journal | 0.793 Q2 | 58 | 36 | 133 | 2397 | 232 | 118 | 1.41 | 66.58 | |
26 | Current Aging Science | journal | 0.441 Q3 | 42 | 33 | 96 | 2138 | 165 | 87 | 1.53 | 64.79 | |
27 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.336 Q3 | 43 | 8 | 79 | 502 | 68 | 67 | 0.81 | 62.75 | |
28 | Current Alzheimer Research | journal | 1.187 Q2 | 103 | 123 | 378 | 7650 | 1221 | 349 | 3.08 | 62.20 | |
29 | Recent Patents on Nanotechnology | journal | 0.286 Q2 | 36 | 26 | 65 | 1570 | 77 | 56 | 1.31 | 60.38 | |
30 | Recent Patents on Endocrine, Metabolic and Immune Drug Discovery | journal | 0.369 Q3 | 28 | 8 | 58 | 478 | 80 | 54 | 1.11 | 59.75 | |
31 | Current Signal Transduction Therapy | journal | 0.129 Q4 | 22 | 9 | 68 | 533 | 13 | 64 | 0.22 | 59.22 | |
32 | Current Hypertension Reviews | journal | 27 | 19 | 87 | 1121 | 117 | 75 | 1.35 | 59.00 | ||
33 | Current Enzyme Inhibition | journal | 0.197 Q4 | 19 | 21 | 56 | 1234 | 36 | 50 | 0.65 | 58.76 | |
34 | Current Chemical Biology | journal | 0.178 Q3 | 26 | 16 | 45 | 917 | 30 | 43 | 0.53 | 57.31 | |
35 | Endocrine, Metabolic and Immune Disorders - Drug Targets | journal | 0.742 Q2 | 63 | 39 | 126 | 2195 | 285 | 117 | 1.99 | 56.28 | |
36 | Central Nervous System Agents in Medicinal Chemistry | journal | 0.423 Q3 | 39 | 28 | 79 | 1570 | 121 | 64 | 1.30 | 56.07 | |
37 | Recent Advances in Drug Delivery and Formulation | journal | 41 | 23 | 70 | 1273 | 98 | 67 | 1.14 | 55.35 | ||
38 | Current Nutrition and Food Science | journal | 0.170 Q4 | 32 | 37 | 131 | 2029 | 56 | 121 | 0.28 | 54.84 | |
39 | Current Drug Delivery | journal | 0.443 Q2 | 72 | 97 | 323 | 5202 | 590 | 307 | 1.67 | 53.63 | |
40 | Medicinal Chemistry | journal | 0.372 Q3 | 50 | 80 | 270 | 4278 | 404 | 261 | 1.69 | 53.48 | |
41 | Current Proteomics | journal | 0.195 Q4 | 27 | 34 | 106 | 1795 | 63 | 98 | 0.56 | 52.79 | |
42 | Current Organocatalysis | journal | 16 | 12 | 56 | 633 | 69 | 52 | 1.26 | 52.75 | ||
43 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.674 Q2 | 108 | 174 | 488 | 9129 | 1081 | 454 | 2.02 | 52.47 | |
44 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.513 Q2 | 45 | 28 | 71 | 1457 | 91 | 64 | 1.13 | 52.04 | |
45 | Current Reviews in Clinical and Experimental Pharmacology | journal | 49 | 38 | 113 | 1897 | 198 | 102 | 1.60 | 49.92 | ||
46 | Current Rheumatology Reviews | journal | 0.586 Q3 | 29 | 29 | 70 | 1445 | 152 | 66 | 2.25 | 49.83 | |
47 | Current Drug Discovery Technologies | journal | 0.449 Q3 | 49 | 23 | 75 | 1136 | 113 | 73 | 1.59 | 49.39 | |
48 | Current Nanoscience | journal | 0.292 Q2 | 52 | 75 | 346 | 3601 | 381 | 322 | 1.21 | 48.01 | |
49 | Combinatorial Chemistry and High Throughput Screening | journal | 0.346 Q3 | 70 | 95 | 288 | 4560 | 304 | 253 | 1.10 | 48.00 | |
50 | Current Bioinformatics | journal | 0.251 Q3 | 38 | 51 | 222 | 2433 | 135 | 202 | 0.52 | 47.71 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®